CRH Investors Logo

CRH Medical Corporation To Present at the 2018 Cantor Fitzgerald Global Healthcare Conference

VANCOUVER, B.C. – September 25, 2018 – CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the “Company”), announces that it will participate in the 2018 Cantor Fitzgerald Global Healthcare Conference at the Intercontinental Barclay Hotel in New York City.

Edward Wright, Chief Executive Officer of the Company is scheduled to present on Wednesday, October 3rd at 10:55 am ET. The Company’s CFO, Richard Bear, will also attend the event.

For more details about the conference, please visit

About CRH Medical Corporation: 

CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 19 anesthesia acquisitions. CRH now serves 45 ambulatory surgical centers in ten states and performs approximately 298,000 procedures annually. In addition, CRH owns the CRH O’Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves. CRH’s O’Regan System is currently used in all 48 lower US states.

Contact information:                                              

Kettina Cordero,
Director of Investor Relations
CRH Medical Corporation
800.660.2153 x1030